1887

Abstract

Proteasomal activator 28 gamma (PA28γ), an essential constituent of the 20S proteasome responsible for ubiquitin-independent degradation of target proteins, is frequently overexpressed in hepatocellular carcinoma. Recently, we have reported that hepatitis B virus (HBV) X protein (HBx) activates PA28γ expression in human hepatocytes via upregulation of p53 levels; however, its role in HBV tumorigenesis remains unknown. Here, we found that HBxactivated PA28γ downregulates p16 levels via ubiquitin-independent proteasomal degradation. As a result, HBx activated the Rb-E2F pathway and stimulated G/S cell cycle progression, resulting in an increase in cell proliferation. The potential of HBx to induce these effects was reproduced in a 1.2-mer HBV replicon and in HBV infection systems and was almost completely abolished by either PA28γ knockdown or p16 overexpression, demonstrating the critical role of the PA28γmediated p16 degradation in HBV tumorigenesis.

Funding
This study was supported by the:
  • Kyung Lib Jang , The National Research Foundation of Korea , (Award NRF-2019R1A2C2011478)
Loading

Article metrics loading...

/content/journal/jgv/10.1099/jgv.0.001461
2020-06-22
2020-10-22
Loading full text...

Full text loading...

References

  1. Liaw Y-F, Chu C-M. Hepatitis B virus infection. Lancet 2009; 373:582–592 [CrossRef][PubMed]
    [Google Scholar]
  2. Lamontagne RJ, Bagga S, Bouchard MJ. Hepatitis B virus molecular biology and pathogenesis. Hepatoma Res 2016; 2:163–186 [CrossRef][PubMed]
    [Google Scholar]
  3. Tsuge M, Hiraga N, Akiyama R, Tanaka S, Matsushita M et al. Hbx protein is indispensable for development of viraemia in human hepatocyte chimeric mice. J Gen Virol 2010; 91:1854–1864 [CrossRef][PubMed]
    [Google Scholar]
  4. Keasler VV, Hodgson AJ, Madden CR, Slagle BL. Enhancement of hepatitis B virus replication by the regulatory X protein in vitro and in vivo. J Virol 2007; 81:2656–2662 [CrossRef][PubMed]
    [Google Scholar]
  5. Liu S, Koh S, Lee C. Hepatitis B virus X protein and hepatocarcinogenesis. Int J Mol Sci 2016; 17:940 [CrossRef]
    [Google Scholar]
  6. Levrero M, Zucman-Rossi J. Mechanisms of HBV-induced hepatocellular carcinoma. J Hepatol 2016; 64:S84–S101 [CrossRef][PubMed]
    [Google Scholar]
  7. Coux O, Tanaka K, Goldberg AL. Structure and functions of the 20S and 26S proteasomes. Annu Rev Biochem 1996; 65:801–847 [CrossRef][PubMed]
    [Google Scholar]
  8. Tomko RJ, Hochstrasser M. Molecular architecture and assembly of the eukaryotic proteasome. Annu Rev Biochem 2013; 82:415–445 [CrossRef][PubMed]
    [Google Scholar]
  9. Mao I, Liu J, Li X, Luo H. Reggamma, a proteasome activator and beyond?. Cell Mol Life Sci 2008; 65:3971–3980 [CrossRef][PubMed]
    [Google Scholar]
  10. Liu J, Yu G, Zhao Y, Zhao D, Wang Y et al. Reggamma modulates p53 activity by regulating its cellular localization. J Cell Sci 2010; 123:4076–4084 [CrossRef][PubMed]
    [Google Scholar]
  11. Zhang Z, Zhang R. Proteasome activator PA28 gamma regulates p53 by enhancing its Mdm2-mediated degradation. Embo J 2008; 27:852–864 [CrossRef][PubMed]
    [Google Scholar]
  12. Chen X, Barton LF, Chi Y, Clurman BE, Roberts JM. Ubiquitin-Independent degradation of cell-cycle inhibitors by the REGgamma proteasome. Mol Cell 2007; 26:843–852 [CrossRef][PubMed]
    [Google Scholar]
  13. Li X, Amazit L, Long W, Lonard DM, Monaco JJ et al. Ubiquitin- and ATP-independent proteolytic turnover of p21 by the REGgamma-proteasome pathway. Mol Cell 2007; 26:831–842 [CrossRef][PubMed]
    [Google Scholar]
  14. He J, Cui L, Zeng Y, Wang G, Zhou P et al. Regγ is associated with multiple oncogenic pathways in human cancers. BMC Cancer 2012; 12:75 [CrossRef][PubMed]
    [Google Scholar]
  15. Okamura T, Taniguchi S-I, Ohkura T, Yoshida A, Shimizu H et al. Abnormally high expression of proteasome activator-gamma in thyroid neoplasm. J Clin Endocrinol Metab 2003; 88:1374–1383 [CrossRef][PubMed]
    [Google Scholar]
  16. Wang X, Tu S, Tan J, Tian T, Ran L et al. Reg gamma: a potential marker in breast cancer and effect on cell cycle and proliferation of breast cancer cell. Med Oncol 2011; 28:31–41 [CrossRef][PubMed]
    [Google Scholar]
  17. Moriishi K, Mochizuki R, Moriya K, Miyamoto H, Mori Y et al. Critical role of PA28gamma in hepatitis C virus-associated steatogenesis and hepatocarcinogenesis. Proc Natl Acad Sci U S A 2007; 104:1661–1666 [CrossRef][PubMed]
    [Google Scholar]
  18. Kim S, Lee H-S, Ji J-H, Cho M-Y, Yoo Y-S et al. Hepatitis B virus X protein activates the ATM-Chk2 pathway and delays cell cycle progression. J Gen Virol 2015; 96:2242–2251 [CrossRef][PubMed]
    [Google Scholar]
  19. Yeom S, Kim SS, Jeong H, Jang KL. Hepatitis B virus X protein activates E3 ubiquitin ligase Siah-1 to control virus propagation via a negative feedback loop. J Gen Virol 2017; 98:1774–1784 [CrossRef][PubMed]
    [Google Scholar]
  20. Wan Z-X, Yuan D-M, Zhuo Y-M, Yi X, Zhou J et al. The proteasome activator PA28γ, a negative regulator of p53, is transcriptionally up-regulated by p53. Int J Mol Sci 2014; 15:2573–2584 [CrossRef][PubMed]
    [Google Scholar]
  21. Yeom S, Jeong H, Kim SS, Jang KL. Hepatitis B virus X protein activates proteasomal activator 28 gamma expression via upregulation of p53 levels to stimulate virus replication. J Gen Virol 2018; 99:655–666 [CrossRef][PubMed]
    [Google Scholar]
  22. Kim Y-J, Jung JK, Lee SY, Jang KL. Hepatitis B virus X protein overcomes stress-induced premature senescence by repressing p16(INK4a) expression via DNA methylation. Cancer Lett 2010; 288:226–235 [CrossRef][PubMed]
    [Google Scholar]
  23. Park S-H, Jung JK, Lim JS, Tiwari I, Jang KL. Hepatitis B virus X protein overcomes all-trans retinoic acid-induced cellular senescence by downregulating levels of p16 and p21 via DNA methylation. J Gen Virol 2011; 92:1309–1317 [CrossRef][PubMed]
    [Google Scholar]
  24. Kobayashi T, Wang J, Al-Ahmadie H, Abate-Shen C. Arf regulates the stability of p16 protein via REGγ-dependent proteasome degradation. Mol Cancer Res 2013; 11:828–833 [CrossRef][PubMed]
    [Google Scholar]
  25. Sun A, Bagella L, Tutton S, Romano G, Giordano A. From G0 to S phase: a view of the roles played by the retinoblastoma (Rb) family members in the Rb-E2F pathway. J Cell Biochem 2007; 102:1400–1404 [CrossRef][PubMed]
    [Google Scholar]
  26. Serrano M, Hannon GJ, Beach D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 1993; 366:704–707 [CrossRef][PubMed]
    [Google Scholar]
  27. Cha M-Y, Ryu D-K, Jung H-S, Chang H-E, Ryu W-S. Stimulation of hepatitis B virus genome replication by HBx is linked to both nuclear and cytoplasmic HBx expression. J Gen Virol 2009; 90:978–986 [CrossRef][PubMed]
    [Google Scholar]
  28. Kwun HJ, Jang KL. Natural variants of hepatitis B virus X protein have differential effects on the expression of cyclin-dependent kinase inhibitor p21 gene. Nucleic Acids Res 2004; 32:2202–2213 [CrossRef][PubMed]
    [Google Scholar]
  29. Rahmani Z, Huh KW, Lasher R, Siddiqui A. Hepatitis B virus X protein colocalizes to mitochondria with a human voltage-dependent anion channel, HVDAC3, and alters its transmembrane potential. J Virol 2000; 74:2840–2846 [CrossRef][PubMed]
    [Google Scholar]
  30. Lee YI, Hwang JM, Im JH, Lee YI, Kim NS, JH I, Kim DG et al. Human hepatitis B virus-X protein alters mitochondrial function and physiology in human liver cells. J Biol Chem 2004; 279:15460–15471 [CrossRef][PubMed]
    [Google Scholar]
  31. Matsuda Y, Sanpei A, Wakai T, Kubota M, Osawa M et al. Hepatitis B virus X stimulates redox signaling through activation of ataxia telangiectasia mutated kinase. Int J Clin Exp Pathol 2014; 7:2032–2043[PubMed]
    [Google Scholar]
  32. Mihara M, Erster S, Zaika A, Petrenko O, Chittenden T et al. P53 has a direct apoptogenic role at the mitochondria. Mol Cell 2003; 11:577–590 [CrossRef][PubMed]
    [Google Scholar]
  33. Vousden KH, Lu X. Live or let die: the cell's response to p53. Nat Rev Cancer 2002; 2:594–604 [CrossRef][PubMed]
    [Google Scholar]
  34. Levine AJ. P53, the cellular gatekeeper for growth and division. Cell 1997; 88:323–331 [CrossRef][PubMed]
    [Google Scholar]
  35. Kong F, You H, Kong D, Zheng K, Tang R. The interaction of hepatitis B virus with the ubiquitin proteasome system in viral replication and associated pathogenesis. Virol J 2019; 16:73 [CrossRef][PubMed]
    [Google Scholar]
  36. Kim S-J, Khan M, Quan J, Till A, Subramani S et al. Hepatitis B virus disrupts mitochondrial dynamics: induces fission and mitophagy to attenuate apoptosis. PLoS Pathog 2013; 9:e1003722 [CrossRef][PubMed]
    [Google Scholar]
  37. Liu D, Cui L, Wang Y, Yang G, He J et al. Hepatitis B e antigen and its precursors promote the progress of hepatocellular carcinoma by interacting with Numb and decreasing p53 activity. Hepatology 2016; 64:390–404 [CrossRef][PubMed]
    [Google Scholar]
  38. Hsieh Y-H, Su I-J, Wang H-C, Tsai J-H, Huang Y-J et al. Hepatitis B virus pre-S2 mutant surface antigen induces degradation of cyclin-dependent kinase inhibitor p27Kip1 through c-Jun activation domain-binding protein 1. Mol Cancer Res 2007; 5:1063–1072 [CrossRef][PubMed]
    [Google Scholar]
  39. Liew CT, Li HM, Lo KW, Leow CK, Chan JY et al. High frequency of p16INK4a gene alterations in hepatocellular carcinoma. Oncogene 1999; 18:789–795 [CrossRef][PubMed]
    [Google Scholar]
  40. Minor MM, Slagle BL. Hepatitis B virus HBx protein interactions with the ubiquitin proteasome system. Viruses 2014; 6:4683–4702 [CrossRef][PubMed]
    [Google Scholar]
  41. Jin M, Piao Z, Kim NG, Park C, Shin EC et al. P16 is a major inactivation target in hepatocellular carcinoma. Cancer 2000; 89:60–68 [CrossRef][PubMed]
    [Google Scholar]
  42. Huang J-Z, Xia S-S, Ye Q-F, Jiang H-Y, Chen Z-H. Effects of p16 gene on biological behaviours in hepatocellular carcinoma cells. World J Gastroenterol 2003; 9:84–88 [CrossRef][PubMed]
    [Google Scholar]
  43. Hinrichsen I, Kemp M, Peveling-Oberhag J, Passmann S, Plotz G et al. Promoter methylation of MLH1, PMS2, MSH2 and p16 is a phenomenon of advanced-stage hCCS. PLoS One 2014; 9:e84453 [CrossRef][PubMed]
    [Google Scholar]
  44. Zhou Y, Wang X-B, Qiu X-P, Shuai Zhang, Wang C et al. Cdkn2A promoter methylation and hepatocellular carcinoma risk: a meta-analysis. Clin Res Hepatol Gastroenterol 2018; 42:529–541 [CrossRef][PubMed]
    [Google Scholar]
  45. Zhang C, Li J, Huang T, Duan S, Dai D et al. Meta-Analysis of DNA methylation biomarkers in hepatocellular carcinoma. Oncotarget 2016; 7:81255–81267 [CrossRef][PubMed]
    [Google Scholar]
  46. Um T-H, Kim H, Oh B-K, Kim MS, Kim KS et al. Aberrant CpG island hypermethylation in dysplastic nodules and early HCC of hepatitis B virus-related human multistep hepatocarcinogenesis. J Hepatol 2011; 54:939–947 [CrossRef][PubMed]
    [Google Scholar]
  47. Feng Q, Stern JE, Hawes SE, Lu H, Jiang M et al. Dna methylation changes in normal liver tissues and hepatocellular carcinoma with different viral infection. Exp Mol Pathol 2010; 88:287–292 [CrossRef][PubMed]
    [Google Scholar]
  48. Zhu Y-Z, Zhu R, Fan J, Pan Q, Li H et al. Hepatitis B virus X protein induces hypermethylation of p16(INK4A) promoter via DNA methyltransferases in the early stage of HBV-associated hepatocarcinogenesis. J Viral Hepat 2010; 17:98–107 [CrossRef][PubMed]
    [Google Scholar]
  49. Zhu Y-Z, Zhu R, Shi L-G, Mao Y, Zheng G-J et al. Hepatitis B virus X protein promotes hypermethylation of p16(INK4A) promoter through upregulation of DNA methyltransferases in hepatocarcinogenesis. Exp Mol Pathol 2010; 89:268–275 [CrossRef][PubMed]
    [Google Scholar]
  50. Park S-H, Lim JS, Lim S-Y, Tiwari I, Jang KL. Hepatitis C virus core protein stimulates cell growth by down-regulating p16 expression via DNA methylation. Cancer Lett 2011; 310:61–68 [CrossRef][PubMed]
    [Google Scholar]
  51. Mendy ME, Kaye S, van der Sande M, Rayco-Solon P, Waight PA et al. Application of real-time PCR to quantify hepatitis B virus DNA in chronic carriers in the Gambia. Virol J 2006; 3:23 [CrossRef][PubMed]
    [Google Scholar]
  52. Kwak J, Choi J-H, Jang KL. Hepatitis C virus Core overcomes all-trans retinoic acid-induced apoptosis in human hepatoma cells by inhibiting p14 expression via DNA methylation. Oncotarget 2017; 8:85584–85598 [CrossRef][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/jgv.0.001461
Loading
/content/journal/jgv/10.1099/jgv.0.001461
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error